XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.

- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.

The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Bitcoin’s $87,000 Rally: Short Squeeze Gives Way to Long Risk
When Bitcoin cleared $85,000 on September 21 , more than $648 million in short positions were liquidated in a single session. Forced buyers — traders whose shor...
Binance Pay Brings USDT Payments to PayPay Locations in Japan
Availability is tied to PayPay-supported locations and eligible Binance Pay users. The announcement does not extend to the full PayPay merchant base by default,...
Ripple Partners With CSD BR on Brazil Financial Market Infrastructure
Ripple has announced a partnership with CSD BR to modernize Brazil’s financial market infrastructure, according to an official announcement on Ripple’s website....
Spot XRP ETFs Reach $121M in September Before Month-End
Spot XRP ETF products have pulled in a reported $121. 4 million in net inflows month-to-date in September, according to unconfirmed reports, with trading days s...
Sentora Proposes 50/50 Aave V4 Revenue Split With DAO
Sentora has submitted a governance proposal to the Aave DAO requesting a 50/50 split of protocol revenue generated by Aave V4, according to the proposal circula...
Illinois Draft Crypto Tax Rules Could Apply From 2027
Illinois has released draft rules that would subject cryptocurrency transactions to state tax obligations beginning in 2027, with the proposed framework applyin...